Mortimer D. Sackler, a psychiatrist who was a co-owner of the pharmaceutical company Purdue Pharma, makers of the controversial painkiller OxyContin, and whose lavish gifts to the Guggenheim Museum, the Metropolitan Museum of Art and Columbia University made him one of New York City's most prominent benefactors, died March 24 in Gstaad, Switzerland. He was 93 and had homes in London, Gstaad and Antibes, France.
His death was confirmed by his daughter Ilene Sackler Lefcourt.
Dr. Sackler, a specialist in psychobiology, did seminal research in the biology of psychiatric illness in the 1940s and '50s, and later established research and training institutes in developmental psychobiology at Columbia and Weill Cornell Medical College as well as at four other universities in England, Scotland and Canada.
A native New Yorker, he began his medical education in Scotland because, he said, quotas kept him, as a Jew, from being admitted to medical school in New York. He lived in Europe since the 1970s, and his philanthropy -- often along with that of his older brother, Arthur, and his younger brother, Raymond -- encompassed both Britain and the European continent.
He was a major donor to Oxford University, Edinburgh University, Glasgow University, the Tate Gallery in London, the Royal College of Art, the Louvre, the Jewish Museum in Berlin and Salzburg University, among other institutions.
In New York, the Sackler brothers were probably best known for the Sackler wing of the Metropolitan Museum of Art, which houses the Temple of Dendur and whose construction they helped finance. Through his foundation, Mortimer Sackler financed the Sackler Center for Arts Education at the Guggenheim, and was a major contributor to the American Museum of Natural History.
The Sackler brothers were all doctors, and all businessmen as well. In 1952, while the three were working at the Creedmoor state psychiatric hospital, Arthur Sackler financed the purchase of a small drug manufacturer based in Greenwich Village, the Purdue Frederick Co., which Mortimer and Raymond Sackler ran as co-chairmen and which later became Purdue Pharma, now based in Stamford, Conn. (The brothers later established several drug companies in other countries.)
In the early years under the Sacklers, Purdue produced among other things an earwax remover, Cerumenex, a laxative marketed under the name Senokot and later the antiseptic Betadine. At the same time, Arthur Sackler was president of a pharmaceutical advertising firm, and he is widely given credit (some would say blame) for creating many of the drug industry's more aggressive marketing techniques -- for example, holding conferences for doctors in which attendees learn about the efficacy of the sponsoring company's drugs.
Arthur Sackler died in 1987, and by the mid-1990s Purdue Pharma was still a small drug company. But with a new product, OxyContin, a powerful, long-acting, narcotic painkiller, the company hoped to join the ranks of industry giants. Indeed, by 2001 sales of the drug had reached nearly $3 billion and accounted for 80 percent of Purdue Pharma's revenue.
But OxyContin also became a widely abused street drug responsible for a number of overdose deaths, which drew legal scrutiny of the company, in particular the claims it had made in marketing the drug.
None of the Sacklers were ever accused of any wrongdoing, but in 2007 Purdue Pharma agreed to pay $600 million in fines and other payments to resolve the charge that the company had misled doctors and patients by claiming that the drug's long-acting quality made it less likely to be abused than traditional narcotics.




Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.